Contents of this Page
<ul>
  <li>
    <a href="#AssayFileExamples-Physico-ChemicalCharacterizationAssays" rel="nofollow">
      Physico-Chemical Characterization Assays
    </a>
    <ul>
      <li>
        <a href="#AssayFileExamples-SizeAssay" rel="nofollow">
          Size Assay
        </a>
        <ul>
          <li>
            <a href="#AssayFileExamples-SizebyDynamicLightScattering(DLS)Assay" rel="nofollow">
              Size by Dynamic Light Scattering (DLS) Assay
            </a>
          </li>
        </ul>
      </li>
      <li>
        <a href="#AssayFileExamples-ZetaPotentialAssay" rel="nofollow">
          Zeta Potential Assay
        </a>
      </li>
    </ul>
  </li>
  <li>
    <a href="#AssayFileExamples-InVitroCharacterizationAssays" rel="nofollow">
      In Vitro Characterization Assays
    </a>
    <ul>
      <li>
        <a href="#AssayFileExamples-CytotoxicityAssays" rel="nofollow">
          Cytotoxicity Assays
        </a>
        <ul>
          <li>
            <a href="#AssayFileExamples-HepatocarcinomaCytotoxicityAssay(MTTandLDH)" rel="nofollow">
              Hepatocarcinoma Cytotoxicity Assay (MTT and LDH)
            </a>
          </li>
          <li>
            <a href="#AssayFileExamples-CaspaseApoptosis" rel="nofollow">
              Caspase Apoptosis
            </a>
          </li>
        </ul>
      </li>
      <li>
        <a href="#AssayFileExamples-BloodContactAssays" rel="nofollow">
          Blood Contact Assays
        </a>
        <ul>
          <li>
            <a href="#AssayFileExamples-HemolysisAssay" rel="nofollow">
              Hemolysis Assay
            </a>
          </li>
        </ul>
      </li>
    </ul>
  </li>
  <li>
    <a href="#AssayFileExamples-InVivoCharacterizationAssays" rel="nofollow">
      In Vivo Characterization Assays
    </a>
    <ul>
      <li>
        <a href="#AssayFileExamples-DispositionandPharmacokineticsAssay" rel="nofollow">
          Disposition and Pharmacokinetics Assay
        </a>
      </li>
    </ul>
  </li>
  <li>
    <a href="#AssayFileExamples-References" rel="nofollow">
      References
    </a>
  </li>
</ul>
The Assay File will vary depending on the type of assay performed and protocol and technology type leveraged. The following sections provide examples of Assay Files for common types of assays identified across nanotechnology resources. Assay File examples were created from assays and protocols performed by the
<a href="http://ncl.cancer.gov" rel="nofollow">
  Nanotechnology Characterization Laboratory (NCL)
</a>
and identified in the
<a href="http://ncl.cancer.gov/working_assay-cascade.asp" rel="nofollow">
  NCL assay cascade
</a>
.
<h2 id="AssayFileExamples-Physico-ChemicalCharacterizationAssays">
  Physico-Chemical Characterization Assays
</h2>
<h3 id="AssayFileExamples-SizeAssay">
  Size Assay
</h3>
<h4 id="AssayFileExamples-SizebyDynamicLightScattering(DLS)Assay">
  Size by Dynamic Light Scattering (DLS) Assay
</h4>
Dynamic Light Scattering (DLS) is a type of spectroscopy that uses a laser beam to irradiate a sample containing particles in suspension resulting in light scattering. Rapid fluctuations in scattering intensity around a mean value at a certain angle occur because of particle diffusion and are dependent upon on particle size. The calculated correlation function yields a diffusion coefficient, for a given temperature and viscosity, that can be used to calculate particle size.
<table>
  <colgroup>
    <col/>
    <col/>
    <col/>
    <col/>
  </colgroup>
  <tbody>
    <tr>
      <th>
        Assay File
      </th>
      <th>
        Assay Factors
      </th>
      <th>
        Assay Measured Values
      </th>
      <th>
        Supporting Information
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_size-DLS_508_c.xls" rel="nofollow">
          Size by DLS
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.org/obo/owl/PATO#PATO_0000146" rel="nofollow">
              Temperature
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1855" rel="nofollow">
              Solvent Medium
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1915" rel="nofollow">
              Hydrodynamic Diameter
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1155" rel="nofollow">
              Polydispersity Index (PDI
            </a>
            )
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_PCC-1.pdf" rel="nofollow">
              Measuring the Size of Nanoparticles in Aqueous Solution using DLS
            </a>
          </li>
          <li>
            <a href="http://www.ncbi.nlm.nih.gov/pubmed/18095846" rel="nofollow">
              Characterization of Nanoparticles for Therapeutics
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/120406.pdf" rel="nofollow">
              Dendrimer-Based MRI Contrast Agents
            </a>
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h3 id="AssayFileExamples-ZetaPotentialAssay">
  Zeta Potential Assay
</h3>
Particle surface characteristics and charge play an important role in the particle’s physical state, stability in different media, agglomeration tendencies, and interaction with biological systems. Zeta potential measurement provides an indirect measure of the net charge and as a tool to test batch-to-batch consistency.
<table>
  <tbody>
    <tr>
      <th>
        Assay File
      </th>
      <th>
        Assay Factors
      </th>
      <th>
        Assay Measured Values
      </th>
      <th>
        Supporting Information
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_zeta_potential_508_c.xls" rel="nofollow">
          Zeta Potential
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1167" rel="nofollow">
              Concentration
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1855" rel="nofollow">
              Solvent Medium
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1302" rel="nofollow">
              Zeta Potential
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_PCC-2.pdf" rel="nofollow">
              Measuring Zeta Potential of Nanoparticles
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/120406.pdf" rel="nofollow">
              Dendrimer-Based MRI Contrast Agents
            </a>
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h2 id="AssayFileExamples-InVitroCharacterizationAssays">
  In Vitro Characterization Assays
</h2>
<h3 id="AssayFileExamples-CytotoxicityAssays">
  Cytotoxicity Assays
</h3>
<h4 id="AssayFileExamples-HepatocarcinomaCytotoxicityAssay(MTTandLDH)">
  Hepatocarcinoma Cytotoxicity Assay (MTT and LDH)
</h4>
The Hepatocarcinoma Cytotoxicity Assay tests the cytotoxicity of nanoparticle formulations in human hepatocarcinoma cells (Hep G2). The protocol utilizes two methods for estimation of cytotoxicity, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction and lactate dehydrogenase (LDH) release (1, 2).The MTT assay is a colorimetric assay that can assess the viability of cells by quantitation of the reduction of the yellow substrate MTT (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to a product that has a purple color. This assay can measure the cytotoxicity of a chemical or drug by determining the affect of treatment on cell viability. The Assay File represents an example for a MTT cytoxicity assay (MTT) performed on three nanoparticle samples, where 9 dilutions of each nanoparticle sample are exposed to porcine proximal tubule cells for three different times of exposure (6h, 2h, and 48 h) (3).LDH is a cytoplasmic enzyme that is released into the cytoplasm upon cell lysis. The LDH assay is a measure of membrane integrity. The basis of the LDH assay: (1) LDH oxidizes lactate to pyruvate, (2) Pyruvate reacts with the tetrazolium salt INT to form formazan, and (3) the water-soluble formazan dye is detected spectrophotometrically (4,5).
<table>
  <tbody>
    <tr>
      <th>
        Assay File
      </th>
      <th>
        Assay Factors
      </th>
      <th>
        Assay Measured Values
      </th>
      <th>
        Supporting Information
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_MTT-LLCPK1_508_c.xls" rel="nofollow">
          Hep G2 Hepatocarcinoma Cytotoxicity Assay (MTT)
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1819" rel="nofollow">
              Time
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1343" rel="nofollow">
              Cell Viability
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_GTA-2.pdf" rel="nofollow">
              Hep G2 Hepatocarcinoma Cytotoxicity Assay Protocol
            </a>
          </li>
          <li>
            <a href="http://www.ncbi.nlm.nih.gov/pubmed/18095846" rel="nofollow">
              Characterization of Nanoparticles for Therapeutics
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/120406.pdf" rel="nofollow">
              Dendrimer-Based MRI Contrast Agents
            </a>
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_LDH-LLCPK1_508_c.xls" rel="nofollow">
          Hep G2 Hepatocarcinoma Cytotoxicity Assay (LDH)
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1819" rel="nofollow">
              Time
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1343" rel="nofollow">
              Cell Viability
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_GTA-2.pdf" rel="nofollow">
              Hep G2 Hepatocarcinoma Cytotoxicity Assay Protocol
            </a>
          </li>
          <li>
            <a href="http://www.ncbi.nlm.nih.gov/pubmed/18095846" rel="nofollow">
              Characterization of Nanoparticles for Therapeutics
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/120406.pdf" rel="nofollow">
              Dendrimer-Based MRI Contrast Agents
            </a>
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h4 id="AssayFileExamples-CaspaseApoptosis">
  Caspase Apoptosis
</h4>
Caspase Apoptosis assays monitor apoptosis by measuring the degree of the caspace (family of cysteine proteases) activity, an indicator of apoptosis. Caspase apoptosis assays measure the cleavage of the DEVD-AFC (Amino Tri-fluoromethyl Coumarin substrate to free AFC. Free AFC emits yellow-green fluorescence (1,2,6).
<table>
  <tbody>
    <tr>
      <th>
        Assay File
      </th>
      <th>
        Assay Factors
      </th>
      <th>
        Assay Measured Values
      </th>
      <th>
        Supporting Information
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_caspase_apoptosis_508_c.xls" rel="nofollow">
          Caspase Apoptosis
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1167" rel="nofollow">
              Concentration
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1855" rel="nofollow">
              Solvent Medium
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C74925" rel="nofollow">
              %
            </a>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C28143" rel="nofollow">
              Control
            </a>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C18153" rel="nofollow">
              Caspase
            </a>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C74925" rel="nofollow">
              Activity
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_GTA-5.pdf" rel="nofollow">
              LLC-PK1 Kidney Cell Apotosis Assay
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/NCL200701A080607.pdf" rel="nofollow">
              Functionalized Fullerenes NCL20071A
            </a>
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h3 id="AssayFileExamples-BloodContactAssays">
  Blood Contact Assays
</h3>
<h4 id="AssayFileExamples-HemolysisAssay">
  Hemolysis Assay
</h4>
Hemolysis refers to the breaking open of red blood cells causing release of hemoglobin into the plasma.  The Hemolysis assay measures the amount of hemoglobin in whole blood (TBH-Total Blood Hemoglobin) and the amount of hemoglobin released into plasma (PFH-Plasma Free Hemoglobin) when blood is exposed to nanoparticles.  Hemoglobin is oxidized to methemoglobin and when reacting with cyanide results in Cyanmethemoblobin (CMH). The hemolysis assay can quantify the acute in vitro hemolytic properties of nanoparticles.
<table>
  <colgroup>
    <col/>
    <col/>
    <col/>
    <col/>
  </colgroup>
  <tbody>
    <tr>
      <th>
        Assay File
      </th>
      <th>
        Assay Factors
      </th>
      <th>
        Assay Measured Values
      </th>
      <th>
        Supporting Information
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_hemolysis_508_c.xls" rel="nofollow">
          Hemolysis
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1167" rel="nofollow">
              Concentration
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C37965" rel="nofollow">
              isHemolytic
            </a>
          </li>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C70467" rel="nofollow">
              Percent Hemolysis
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_ITA-1.pdf" rel="nofollow">
              Analysis of Hemolytic Properties of Nanoparticles
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/120406.pdf" rel="nofollow">
              Dendrimer-Based MRI Contrast Agents
            </a>
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h2 id="AssayFileExamples-InVivoCharacterizationAssays">
  In Vivo Characterization Assays
</h2>
<h3 id="AssayFileExamples-DispositionandPharmacokineticsAssay">
  Disposition and Pharmacokinetics Assay
</h3>
The Disposition and Pharmacokinetics assay is performed to determine the fate of a nanoparticle formulation in an organism, which can include its absorption, tissue distribution, metabolism or excretion (ADME). This is accomplished by detecting the whole formulation or its components at various body locations and time points after dosing. A variety of methods can be used to detect and quantify nanoparticle formulations and their components in vivo.
<table>
  <colgroup>
    <col/>
    <col/>
    <col/>
    <col/>
  </colgroup>
  <tbody>
    <tr>
      <th>
        Assay File
      </th>
      <th>
        Assay Factors
      </th>
      <th>
        Assay Measured Values
      </th>
      <th>
        Supporting Information
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_pharmacokinetic_508_c.xls" rel="nofollow">
          Pharmacokinetics
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1819" rel="nofollow">
              Time
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C70914" rel="nofollow">
              Clearance
            </a>
            at
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C78441" rel="nofollow">
              Time Zero
            </a>
            (C0)
          </li>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C64774" rel="nofollow">
              Area Under Curve (AUC)
            </a>
          </li>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C70914" rel="nofollow">
              Clearance (CL)
            </a>
          </li>
          <li>
            <a href="http://purl.org/obo/owl/UO#UO_0000152" rel="nofollow">
              Half Life (T 1/2)
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1524" rel="nofollow">
              Volume of Distribution (V app)
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_Disposition_and_PK.pdf" rel="nofollow">
              Distribution and Pharmcokinetics Description
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/MK_022207_073007.pdf" rel="nofollow">
              Ceramide Liposomes NCL200702A
            </a>
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/download/attachments/252772694/a_distribution_508_c.xls" rel="nofollow">
          Tissue Distribution
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://purl.bioontology.org/ontology/npo#NPO_1819" rel="nofollow">
              Time
            </a>
            <a href="http://www.cancer.gov/policies/linking" rel="nofollow">
              <img alt="Exit Disclaimer logo" src="https://wiki.nci.nih.gov/download/attachments/embedded-page/wikicontent/Exit%20Disclaimer%20to%20Include/exit_small.png?api=v2">
            </a>
          </li>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C12801" rel="nofollow">
              Tissue
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C71876" rel="nofollow">
              Tissue Distribution
            </a>
          </li>
        </ul>
      </td>
      <td>
        <ul>
          <li>
            <a href="http://ncl.cancer.gov/NCL_Method_Disposition_and_PK.pdf" rel="nofollow">
              Distribution and Pharmcokinetics Description
            </a>
          </li>
          <li>
            <a href="http://ncl.cancer.gov/MK_022207_073007.pdf" rel="nofollow">
              Ceramide Liposomes NCL200702A
            </a>
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h2 id="AssayFileExamples-References">
  References
</h2>
<ol>
  <li>
    ISO 10993-5 Biological evaluation of medical devices: Part 5 Tests for in vitro  cytotoxicity.
  </li>
  <li>
    F1903 – 98 Standard Practice for Testing for Biological Responses to Particles in vitro.
  </li>
  <li>
    Alley, et al. (1988) Cancer Res.   48:589-601.
  </li>
  <li>
    Decker, T. &amp; Lohmann-Matthes, M.L. (1988) J. Immunol Methods  15:61-69.
  </li>
  <li>
    Korzeniewski, C. &amp; Callewaert, D.M. (1983) J. Immunol Methods  64:313-320.
  </li>
  <li>
    Wang et al. (2005) Cell Bio. Int. 29: 489-496.
  </li>
</ol>
Help Downloading FilesFor help accessing PDF, audio, video, and compressed files on this wiki, go to
<a href="https://wiki.nci.nih.gov/pages/viewpage.action?pageId=328991650" rel="nofollow">
  Help Downloading Files
</a>
.